Filters close
Released: 22-Nov-2016 9:00 AM EST
Rep. Susan Brooks Visits New Specialized Pharmacy
Cordant Health Solutions

Rep. Susan Brooks (R-IN05) met with pharmacists (cite names as pictured) working in a new controlled substances pharmacy recently opened in Indianapolis by Cordant Health Solutions.

   
Released: 9-Jun-2010 4:20 PM EDT
Spectrum Dynamics Begins Ultra Low Dose Radiation Studies
Spectrum Dynamics

Spectrum Dynamics announced it has begun clinical studies to show that its D-SPECT™ technology can accommodate significantly lower doses of radiopharmaceutical agents so the total radiation exposure to patients and staff is much lower compared to conventional cardiac imaging.

Released: 20-Nov-2009 9:00 AM EST
FISH Technology Preferred for Choosing HER-2-Positive Breast Cancer Treatments
Abbott Molecular

The debate on how to select patients who will respond best to costly drug treatments for aggressive breast cancer now favors fluorescence in situ hybridization (FISH) to measure the HER-2 receptor found in human breast tumors, according to a leading pathologist presenting at the Association for Molecular Pathology annual meeting.

Released: 20-Nov-2009 8:00 AM EST
New Abbott Technology Offers Rapid Alternative to Culture for Microbial Detection
Abbott Molecular

Research presented today at the Association for Molecular Pathology (AMP) annual meeting indicates that a new molecular diagnostic technology from Abbott identified more microbes and delivered more rapid results than traditional culture testing methods.

Released: 8-May-2009 10:30 AM EDT
HIV/AIDS Research Network Recommends Use of Abbott RealTime Viral Load Test for NIH-Sponsored Clinical Trials
Weber & Associates

The Abbott RealTime HIV-1 Assay and Abbott m2000 System have been recommended as a standard protocol for viral load testing in HIV/AIDS clinical trials sponsored by the National Institutes of Health (NIH).

Released: 6-Oct-2008 12:25 PM EDT
AIDS Research Pioneer Robert Gallo, M.D., Keynotes Abbott HIV Symposium, Oct. 24
Weber & Associates

On Friday, October 24 at 3 p.m. at the National Press Club in Washington, D.C., Abbott will host a symposium titled: HIV Diagnosis and Therapy, Beyond B: Challenges for the Future. The keynote speaker is Robert Gallo, M.D., known worldwide for identifying the HIV virus in 1984 as the causative agent of AIDS.

Released: 9-Jun-2008 11:00 AM EDT
Variant HIV Subtypes on the Rise
N/A

An ongoing concern for public health authorities and infectious disease experts is the ability of deadly pathogens to adapt or mutate and become difficult to detect and treat. One of the more clever bugs is the HIV virus, which has numerous strains and subtypes that may elude detection. The problem has intensified as the world continues to shrink. Many studies have reported that the growing population of immigrants from countries where variant strains are more common has caused a significant increase in newly diagnosed HIV patients infected with variant, possibly drug-resistant strains.


Showing results 1 – 7 of 7


close
0.08751